Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights
Yaonan Song(Tongji Hospital), Dao Wen Wang(Tongji Hospital), Weijian Hang(Tongji Hospital), Junfang Wu(Laboratory of Molecular Genetics), Huiqing Wang(Guangdong Pharmaceutical University), Zhitong Zhou(Jiangnan University), Haoran Wei(Tongji Hospital)
Cited by 27
Related Papers
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Gut Microbiota Composition Modifies Fecal Metabolic Profiles in Mice
|Journal of Proteome Research|2013|225
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159